NCHC

National Coalition On Health Care

  • About Us
    • Members and Supporters
    • Board of Directors
    • Staff
    • Annual Reports
  • Policy
    • COVID-19 Response
    • Make Prescription Drugs More Affordable
    • Eliminate Surprise Medical Billing
    • Make Health Care Affordable and Accessible
    • Promote a High-Value Health Care System that Supports Vulnerable Populations
  • Blog
  • Events
  • Newsroom
    • Press Releases
    • NCHC In The News
    • Policy Correspondence
    • Fact Sheets & Issue Briefs
  • Get Involved
    • Become a Member
    • Become a Funder
    • Career Opportunities & Internships
  • Contact Us

The Campaign for Sustainable Rx Pricing Responds to PhRMA CEO’s Defense of Solvaldi’s Price Tag

June 5, 2014 By Larry McNeely

Tweet
Share

In a recent post in The Catalyst (“Focus on Prices is Penny Wise and Pound Foolish”), PhRMA President & CEO, John Castellani, seeks to defend the $1,000-a-pill price tag attached to Gilead Sciences’ new breakthrough hepatitis C drug, Sovaldi.  It’s an unusual move for the CEO of PhRMA to defend the price of one particular drug and it seems especially unusual given that Gilead doesn’t even appear to be a member of PhRMA.  One wonders if PhRMA members are anxious to have Sovaldi define their industry?

He argues, correctly, that drugs often save money for the health care system.  We believe that medicines can be one of the best and most cost-effective interventions in health care and, of course, cost-effectiveness can’t be the only lens we apply to new innovation.  For example, there are many very expensive drugs for rare diseases that simply can’t be cost-effective, but as a society we understand we have to pay the price for innovation.

The problem that Sovaldi has spotlighted is that some companies are attempting to charge rare-disease prices for medicines that will be used by many, many people.  In Sovaldi’s case it will be used by many millions in the U.S. and around the world.

Mr. Castellani attempts to redirect blame for the problem to payers, but the real issue is the total cost to the system.  Whether the cost is embedded in government or employer subsidies, premiums, or co-pays, the cost is the cost and the trend for high-priced medicines is on a collision course with reality.  Pointing fingers won’t solve the problem.

Mr. Castellani closes his post by calling for a “much broader conversation” on the ways we can create a sustainable health care system that will carry us into the 21stcentury, while also protecting patients and encouraging innovation.  As the head of the National Coalition on Health Care (NCHC), a nationwide alliance spanning multiple industries and comprised of over 80 employers, providers, consumer, and public health groups, we recently launched a campaign to encourage such a dialogue.

The Campaign for Sustainable Rx Pricing welcomes the opportunity to discuss this important issue with the pharmaceutical industry.  We believe that by focusing on quality, proven results, and the utilization of comparative effectiveness research, our health care system can reap the benefits of advances in not only medicines, but new technologies, medical techniques, and coordinated models of care.

Filed Under: Blog

Mission

To bring together key stakeholders in order to achieve an affordable, high-value health care system for patients and consumers, for employers and other payers, and for taxpayers.

Signup for NCHC Newsletter

NCHC Recent Policy Correspondence

  • The Budget Reconciliation Process and NCHC Priorities in 2021
  • NCHC STATEMENT ON BICAMERAL AND BIPARTISAN SURPRISE BILLING LEGISLATION, “NO SURPRISES ACT,”
  • NCHC STATEMENT ON PART D REBATE SAFE HARBOR REPEAL AND “MOST FAVORED NATION” DEMONSTRATION
  • NCHC Statement On The Trump Administration’s “Most-Favored-Nation” Drug Pricing Executive Order
  • NCHC Statement on the Trump Administration’s Executive Orders
...More Policy Correspondence

National Coalition on Health Care

About Us

The National Coalition on Health Care (NCHC) was formed more than two decades ago to help achieve comprehensive health system change and is currently led by John Rother. We aim to be a leader in promoting a healthy population and a more effective, efficient and responsive health system that provides quality care for all. NCHC is a nonpartisan, nonprofit organization of organizations. Our growing Coalition represents more than 80 participating organizations, including medical societies, businesses, unions, health care providers, faith-based associations, pension and health funds, insurers, and groups representing consumers, patients, women, … Read More...

Interim CEO

Shawn Martin

CHAIRMAN

Jack Lewin
Principal and Founder
Lewin and Associates, LLC

MISSION

To bring together key stakeholders in order to achieve an affordable, high-value health care system for patients and consumers, for employers and other payers, and for taxpayers.

CONTACT US

900 16th Street NW, Suite 400
Washington, DC 20006
contactus@nchc.org

Connect With NCHC

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Recent News & Posts

  • National Coalition on Health Care and West Health, The Burden of High Drug Prices on Communities of Color
  • NCHC ANNOUNCES RETIREMENT OF PRESIDENT JOHN ROTHER
  • NCHC & West Health Hill Briefing: The Burden of High Drug Prices Among Communities of Color
  • Reference Pricing: A Bipartisan Solution to High Hospital Prices?
  • The Budget Reconciliation Process and NCHC Priorities in 2021

Recent Tweets

Tweets by NC_HC

Copyright © 2021 · Outreach Pro Theme on Genesis Framework · WordPress · Log in